MoonLake Immunotherapeutics
MLTX
MLTX
45 hedge funds and large institutions have $113M invested in MoonLake Immunotherapeutics in 2021 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
45
Holders Change
+2
Holders Change %
+4.65%
% of All Funds
0.69%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
5
Reduced
5
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Fidelity Investments
Boston,
Massachusetts
|
$11.8M |
| 2 |
2
Marshall Wace
London,
United Kingdom
|
$5.27M |
| 3 |
6CM
3
683 Capital Management
New York
|
$5.84M |
| 4 |
CS
4
Credit Suisse
Zurich,
Switzerland
|
$3.68M |
| 5 |
AWG
5
Alpha Wave Global
New York
|
$3.04M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
BCLSI
51
Bain Capital Life Sciences Investors
Boston,
Massachusetts
| – | -$2.49M | -250,000 | Closed |
|
|
FCMV
52
Foresite Capital Management V
Larkspur,
California
| – | -$2.49M | -250,000 | Closed |
|
|
RSCM
53
Rock Springs Capital Management
Baltimore,
Maryland
| – | -$1.54M | -154,500 | Closed |
|
|
CAC
54
Cowen and Company
New York
| – | -$622K | -62,475 | Closed |
|
|
GCL
55
Glazer Capital LLC
New York
| – | -$577K | -58,541 | Closed |
|
|
EAM
56
Exos Asset Management
New York
| – | -$250K | -25,100 | Closed |
|
57
Janus Henderson Group
London,
United Kingdom
| – | -$150K | -15,168 | Closed |
|